ATHEROSCLEROTIC CARDIOVASCULAR DISEASE (ASCVD)
Clinical trials for ATHEROSCLEROTIC CARDIOVASCULAR DISEASE (ASCVD) explained in plain language.
Never miss a new study
Get alerted when new ATHEROSCLEROTIC CARDIOVASCULAR DISEASE (ASCVD) trials appear
Sign up with your email to follow new studies for ATHEROSCLEROTIC CARDIOVASCULAR DISEASE (ASCVD), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug aims to shield heart and kidneys in High-Risk patients
Disease control OngoingThis study tests a medication called retatrutide to see if it can lower the chance of serious heart problems (like heart attacks or strokes) and slow down kidney disease in people who are overweight and already have heart or kidney issues. About 10,000 adults will take either the…
Matched conditions: ATHEROSCLEROTIC CARDIOVASCULAR DISEASE (ASCVD)
Phase: PHASE3 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated May 15, 2026 11:57 UTC
-
Massive heart trial targets hidden fat risk factor
Disease control OngoingThis large Phase 3 study tests an injectable drug called lepodisiran in about 17,300 adults with high levels of lipoprotein(a), a genetic risk factor for heart disease. Participants either already have heart disease or are at high risk for a first heart attack or stroke. The goal…
Matched conditions: ATHEROSCLEROTIC CARDIOVASCULAR DISEASE (ASCVD)
Phase: PHASE3 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated May 11, 2026 20:53 UTC